Felbamate Tablet
Product Images NDC 62559-731

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 62559-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ani (Ani 01)

FDA Label Image

Ani (Ani 02)

FDA Label Image

Ani (Ani)

FDA Label Image

Structural Formula (Felbamate Tablets 1)

Chemical structure of Felbamate, displaying its molecular configuration with phenyl and carbamate groups. The structure includes depicted atoms and bonds characteristic of Felbamate.*

FDA Label Image

Image 01

Label for Felbamate Tablets USP 400 mg oral tablets. The label shows 100 tablets per container, distributed by ANI Pharmaceuticals, Inc. and manufactured by Bora Pharmaceutical Laboratories Inc., Jhunan, Taiwan. It includes storage instructions, a barcode, and a statement to keep medication out of reach of children.*

FDA Label Image

Image 02

Felbamate Tablets USP 600 mg oral tablet label for prescription use. The label indicates 100 tablets per container, manufactured by Bora Pharmaceutical Laboratories Inc., Jhunan, Taiwan, and distributed by ANI Pharmaceuticals, Inc., Baudette, MN. It includes storage instructions and a warning to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.